Re: if the partial sale of zen
|
5
|
Resverlogix Corp.
|
Aug 08, 2024 01:03PM
|
Re: New Share Price Contest
|
5
|
Resverlogix Corp.
|
Oct 12, 2019 08:32AM
|
Re: CALGARY, Alberta, March 02, 2023 - Resverlogix Corp.
|
5
|
Resverlogix Corp.
|
Mar 05, 2023 11:22AM
|
Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
|
5
|
Resverlogix Corp.
|
Mar 26, 2020 06:29PM
|
Address your Shareholders Donald J. McCaffrey
|
5
|
Resverlogix Corp.
|
May 13, 2020 12:11PM
|
Re: something that looks somewhat positive?
|
5
|
Resverlogix Corp.
|
Oct 15, 2022 01:07PM
|
Re: Quote from a January 19, 2021 review
|
5
|
Resverlogix Corp.
|
Jan 21, 2021 09:43AM
|
Re: Covid-19 trial in France dated Mar 20th, ... interesting
|
5
|
Resverlogix Corp.
|
Mar 28, 2020 06:12PM
|
hitting a new 52 week low
|
5
|
Resverlogix Corp.
|
Sep 17, 2019 10:46AM
|
Re: well according to HQ/Sarah we have been kept in loop all along....
|
5
|
Resverlogix Corp.
|
May 17, 2022 12:24PM
|
Re: The cardiac pre-print now published....in Cell!
|
5
|
Resverlogix Corp.
|
Mar 16, 2021 05:30PM
|
Re: Drop in price
|
5
|
Resverlogix Corp.
|
Jul 08, 2021 05:47PM
|
Re: significant drop in short interest on Rvxcf
|
5
|
Resverlogix Corp.
|
Sep 30, 2024 12:04PM
|
Re: Drugmakers, scientists begin the hunt for long COVID treatments
|
5
|
Resverlogix Corp.
|
Mar 25, 2022 01:45PM
|
Has dosing started /commenced? - from Sarah
|
5
|
Resverlogix Corp.
|
Oct 19, 2021 11:51AM
|
Re: Zenith AGM?
|
5
|
Zenith Epigenetics
|
Sep 30, 2024 12:53PM
|
Re: Another crazy week....
|
5
|
Resverlogix Corp.
|
Mar 20, 2020 06:49PM
|
Re: possible catalyst(s)??
|
5
|
Zenith Epigenetics
|
Dec 20, 2021 01:36PM
|
Re: ZEN-3694 and Enzalutamide 2b Trial - Astella owns a piece of Xtandi (aka Enzalutamide)
|
5
|
Zenith Epigenetics
|
Apr 22, 2021 01:18PM
|
Re: GV on stock house
|
5
|
Resverlogix Corp.
|
Apr 08, 2021 01:47PM
|